Detalhe da pesquisa
1.
Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia.
Blood
; 141(9): 996-1006, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108341
2.
Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
J Allergy Clin Immunol
; 153(1): 297-308.e12, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979702
3.
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation.
Ann Hematol
; 103(2): 553-563, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951851
4.
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.
Ann Hematol
; 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436671
5.
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(5): 1008-1011, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425185
6.
Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma.
Eur J Haematol
; 110(3): 296-304, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433728
7.
Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study.
J Med Internet Res
; 25: e46017, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606979
8.
Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal.
J Med Internet Res
; 23(6): e26022, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34100765
9.
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.
Br J Haematol
; 191(5): 764-774, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583458
10.
Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas.
Ann Hematol
; 99(9): 2125-2132, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613279
11.
The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic event.
Am J Hematol
; 95(12): 1562-1571, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936982
12.
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Am J Hematol
; 95(9): 1030-1037, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32419224
13.
Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.
J Clin Apher
; 35(3): 227-230, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142176
14.
Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. Int. J. Mol. Sci. 2019, 20, 1808.
Int J Mol Sci
; 21(16)2020 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785029
15.
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma.
Br J Cancer
; 121(9): 751-757, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558804
16.
Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
Ann Hematol
; 98(11): 2569-2578, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628518
17.
Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome Registry.
Eur J Cancer Care (Engl)
; 28(6): e13154, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465136
18.
Curcumin: New Insights into an Ancient Ingredient against Cancer.
Int J Mol Sci
; 20(8)2019 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013694
19.
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Lancet Oncol
; 19(3): 370-381, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29429912
20.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295